We demonstrated that, in distinction to classical opioid receptors, ACKR3 doesn't induce classical G protein signaling and isn't modulated through the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. In its place, we proven that LIH383, an ACKR3-selective subnanomolar competitor https://richardp405bsi0.oneworldwiki.com/user